A spokesperson confirmed the Danish drugmaker has asked U.S. regulators to clear an oral version of its weight loss drug ...

Nearly two years after reporting successful results from a phase 3 trial of its oral version of injected obesity treatment ...

The FDA has approved the popular drug Dupixent (generic name, dupilumab) for adults and kids 12 and up with chronic spontaneous urticaria (CSU), a long-lasting itchy skin condition, when regular ...

Many compounding pharmacies are no longer allowed to make cheaper versions of semaglutide and other GLP-1 drugs. A doctor ...

As the FDA cracks down on compounded GLP-1 drugs like semaglutide and tirzepatide, the market for GLP-1 supplements is taking ...

UCB also notes that unlike monoclonal antibody C5 inhibitors Zilbrysq is a smaller peptide molecule ... The new drug joins UCB’s recently FDA-approved FcRn-targeting antibody Rystiggo ...

Novo doesn’t have any small molecule obesity drug that as close to approval. It does have an approved GLP-1 pill on the market, but it’s a peptide that’s difficult to manufacture.

Bristol Myers Squibb today announced that the U.S. Food and Drug Administration (FDA) has updated the U.S. Prescribing Information for CAMZYOS® (mavacamten, 2.5 mg, 5 mg, 10 mg, 15 mg capsules), ...

When I say I’ve been getting Botox my entire adult life, I’m not exaggerating one bit—I started at the ripe, young age of 19 ...

It's the second drug in the TFPI class to be approved by the FDA after ... and liraglutide has been on the shortages list since 2023. Earlier this year, Teva launched an authorised generic version ...

We recently published a list of the 13 Best Biotech Penny Stocks to Buy According to Hedge Funds. In this article, we are ...

Lilly said it would seek approval from ... acts exactly like a peptide. Researchers at Chugai Pharmaceutical Co., a Japanese company, figured out a way, licensing their drug to Lilly in 2018.